(Hypertension. 1997;30:42-49.)
© 1997 American Heart Association, Inc.
Articles |
Angiotensin II Type 1 (AT1) Receptor–Mediated Accumulation of Angiotensin II in Tissues and Its Intracellular Half-life In Vivo
From the Departments of Internal Medicine (J.P. van K., L.M. de L., M.A.D.H.S.), Experimental Cardiology (J.P. van K., J.R. van M., P.D.V.), and Pharmacology (L.M. de L., A.H.J.D.), Cardiovascular Research Institute Erasmus University Rotterdam (COEUR) (the Netherlands).
Correspondence to A.H.J. Danser, PhD, Department of Pharmacology, Room EE 1418 B, Erasmus University Rotterdam, Dr. Molewaterplein 50, 3015 GE Rotterdam, Netherlands. E-mail danser{at}farma.fgg.eur.nl
Abstract Angiotensin II (Ang II) is internalized by various cell types via receptor-mediated endocytosis. Little is known about the kinetics of this process in the whole animal and about the half-life of intact Ang II after its internalization. We measured the levels of 125I–Ang II and 125I–Ang I that were reached in various tissues and blood plasma during infusions of these peptides into the left cardiac ventricle of pigs. Steady-state concentrations of 125I–Ang II in skeletal muscle, heart, kidney, and adrenal were 8% to 41%, 64% to 150%, 340% to 550%, and 680% to 2100%, respectively, of the 125I–Ang II concentration in arterial blood plasma (ranges of six experiments). The tissue concentrations of 125I–Ang I were less than 5% of the arterial plasma concentrations. 125I–Ang II accumulation seen in heart, kidney, and adrenal was almost completely blocked by a specific Ang II type 1 (AT1) receptor antagonist. Steady-state concentrations of 125I–Ang II were reached within 30 to 60 minutes in the tissues and within 5 minutes in blood plasma. The in vivo half-life of intact 125I–Ang II in heart, kidney, and adrenal was approximately 15 minutes, compared with 0.5 minute in the circulation. Thus, Ang II, but not Ang I, from the circulation is accumulated by some tissues, and this is mediated by AT1 receptors. The time course of this process and the long half-life of the accumulated Ang II support the contention that this Ang II has been internalized after its binding to the AT1 receptor, so that it is protected from rapid degradation by endothelial peptidases. The results of this study are in agreement with growing evidence of an important physiological role for internalized Ang II.
Key Words: angiotensin II • receptors, angiotensin • adrenal glands • endocytosis • heart • kidney
This article has been cited by other articles:
 |
|
 |
|
  V. P. Singh, B. Le, R. Khode, K. M. Baker, and R. Kumar Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis Diabetes, December 1, 2008; 57(12): 3297 - 3306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, M. Molina-Molina, A. Abdul-Hafez, V. Uhal, A. Xaubet, and B. D. Uhal Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L178 - L185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. C. Li and J. L. Zhuo In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice Am J Physiol Renal Physiol, February 1, 2008; 294(2): F293 - F302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Ortiz Delineating the contributions of AT1a and AT1b receptor-mediated uptake of ANG II in kidneys and adrenals Am J Physiol Renal Physiol, February 1, 2008; 294(2): F291 - F292. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P. Singh, B. Le, V. B. Bhat, K. M. Baker, and R. Kumar High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H939 - H948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Zhuo and X. C Li Review: Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 23 - 33. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Wei, J. R. Sowers, R. Nistala, H. Gong, G. M.-E. Uptergrove, S. E. Clark, E. M. Morris, N. Szary, C. Manrique, and C. S. Stump Angiotensin II-induced NADPH Oxidase Activation Impairs Insulin Signaling in Skeletal Muscle Cells J. Biol. Chem., November 17, 2006; 281(46): 35137 - 35146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Baker and R. Kumar Intracellular angiotensin II induces cell proliferation independent of AT1 receptor Am J Physiol Cell Physiol, November 1, 2006; 291(5): C995 - C1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G Burniston, A. Saini, L.-B. Tan, and D. F Goldspink Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat Exp Physiol, September 1, 2005; 90(5): 755 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pilz, E. Shagdarsuren, M. Wellner, A. Fiebeler, R. Dechend, P. Gratze, S. Meiners, D. L. Feldman, R. L. Webb, I. M. Garrelds, et al. Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats Hypertension, September 1, 2005; 46(3): 569 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gonzalez-Villalobos, R. B. Klassen, P. L. Allen, L. G. Navar, and T. G. Hammond Megalin binds and internalizes angiotensin II Am J Physiol Renal Physiol, February 1, 2005; 288(2): F420 - F427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Thai, J. Wollmuth, S. Goldman, and M. Gaballa Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2 Receptor J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1171 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Reckelhoff and J. C. Romero Role of oxidative stress in angiotensin-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. K. Leong, Y. Zhang, L. E. Yang, N.-H. Holstein-Rathlou, and A. A. McDonough Diuretic response to acute hypertension is blunted during angiotensin II clamp Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R837 - R842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Podesser, J. Schirnhofer, O. Y. Bernecker, A. Kroner, M. Franz, S. Semsroth, B. Fellner, J. Neumuller, S. Hallstrom, and E. Wolner Optimizing Ischemia/Reperfusion in the Failing Rat Heart--Improved Myocardial Protection With Acute ACE Inhibition Circulation, September 24, 2002; 106(12_suppl_1): I-277 - I-283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Korn, A. Kroner, J. Schirnhofer, S. Hallstrom, O. Bernecker, R. Mallinger, M. Franz, H. Gasser, E. Wolner, and B. K. Podesser Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 352 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Perry, C.-C. Wei, G. H. Hankes, S. R. Dillon, P. Rynders, R. Mukherjee, F. G. Spinale, and L. J. Dell'Italia Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1374 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Broome, M. Haney, B. Osterlund, S. Haggmark, G. Johansson, and B. Biber The Cardiac Effects of Intracoronary Angiotensin II Infusion Anesth. Analg., April 1, 2002; 94(4): 787 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Eto, Y. Ohya, Y. Nakamura, I. Abe, and M. Iida Intracellular Angiotensin II Stimulates Voltage-Operated Ca2+ Channels in Arterial Myocytes Hypertension, February 1, 2002; 39(2): 474 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Saris, M. M.E.D. van den Eijnden, J. M.J. Lamers, P. R. Saxena, M. A.D.H. Schalekamp, and A.H. J. Danser Prorenin-Induced Myocyte Proliferation: No Role for Intracellular Angiotensin II Hypertension, February 1, 2002; 39(2): 573 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M Filipeanu, R. H Henning, S A. Nelemans, and D. de Zeeuw Review: Intracellular angiotensin II: from myth to reality? Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 219 - 226. [PDF]
|
|
|
|
 |
|
 M. E. Gerlofs-Nijland, K. J. M. Assmann, H. B. P. M. Dijkman, J. W.C. Dieker, J. P. H. F. van Son, S. Mentzel, J. P. van Kats, A. H. J. Danser, O. Smithies, P. J. T. A. Groenen, et al. Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A: Role of Angiotensin II J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2711 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. E. D. van den Eijnden, J. J. Saris, R. J. A. de Bruin, E. de Wit, W. Sluiter, T. L. Reudelhuber, M. A. D. H. Schalekamp, F. H. M. Derkx, and A. H. J. Danser Prorenin Accumulation and Activation in Human Endothelial Cells : Importance of Mannose 6-Phosphate Receptors Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 911 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dalla Libera, B. Ravara, A. Angelini, K. Rossini, M. Sandri, G. Thiene, G. Battista Ambrosio, and G. Vescovo Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure Circulation, May 1, 2001; 103(17): 2195 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L G. Navar, K. D Mitchell, L. M Harrison-Bernard, H. Kobori, and A. Nishiyama Review: Intrarenal angiotensin II levels in normal and hypertensive states Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S176 - S184. [PDF]
|
|
|
|
 |
|
 S. E. Gordon, B. S. Davis, C. J. Carlson, and F. W. Booth ANG II is required for optimal overload-induced skeletal muscle hypertrophy Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E150 - E159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. van Kats, D. J. Duncker, D. B. Haitsma, M. P. Schuijt, R. Niebuur, R. Stubenitsky, F. Boomsma, M. A. D. H. Schalekamp, P. D. Verdouw, and A. H. J. Danser Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade Prevent Cardiac Remodeling in Pigs After Myocardial Infarction : Role of Tissue Angiotensin II Circulation, September 26, 2000; 102(13): 1556 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. AMANN, L. C. RUMP, A. SIMONAVICIENE, V. OBERHAUSER, S. WESSELS, S. R. ORTH, M.-L. GROSS, A. KOCH, G. W. BIELENBERG, J. P. VAN KATS, et al. Effects of Low Dose Sympathetic Inhibition on Glomerulosclerosis and Albuminuria in Subtotally Nephrectomized Rats J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1469 - 1478. [Abstract] [Full Text]
|
|
|
|
|
|
W. C. De Mello and A. H. J. Danser Angiotensin II and the Heart : On the Intracrine Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1183 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Gavin, D. A. Spector, H. Wagner, E. C. Breen, and P. D. Wagner Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise J Appl Physiol, May 1, 2000; 88(5): 1690 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.H.J. Danser, J. J Saris, M. P Schuijt, and J. P van Kats Is there a local renin--angiotensin system in the heart? Cardiovasc Res, November 1, 1999; 44(2): 252 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Dostal and K. M. Baker The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function? Circ. Res., October 1, 1999; 85(7): 643 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Imig, G. L. Navar, L.-X. Zou, K. C. O'Reilly, P. L. Allen, J. H. Kaysen, T. G. Hammond, and L. G. Navar Renal endosomes contain angiotensin peptides, converting enzyme, and AT1A receptors Am J Physiol Renal Physiol, August 1, 1999; 277(2): F303 - F311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A.M van Kesteren, J. J Saris, D. H.W Dekkers, J. M.J Lamers, P. R Saxena, M. A.D.H Schalekamp, and A.H.J. Danser Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II Cardiovasc Res, July 1, 1999; 43(1): 148 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamada, S. N. Iyer, M. C. Chappell, D. Ganten, and C. M. Ferrario Converting Enzyme Determines Plasma Clearance of Angiotensin-(1–7) Hypertension, September 1, 1998; 32(3): 496 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. van Kats, A. H. J. Danser, J. R. van Meegen, L. M. A. Sassen, P. D. Verdouw, and M. A. D. H. Schalekamp Angiotensin Production by the Heart : A Quantitative Study in Pigs With the Use of Radiolabeled Angiotensin Infusions Circulation, July 7, 1998; 98(1): 73 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. de Lannoy, A.H. J. Danser, A. M.B. Bouhuizen, P. R. Saxena, and M. A.D.H. Schalekamp Localization and Production of Angiotensin II in the Isolated Perfused Rat Heart Hypertension, May 1, 1998; 31(5): 1111 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Hilgers, E. Bingener, C. Stumpf, D. N. Muller, R. E. Schmieder, and R. Veelken Angiotensinases Restrict Locally Generated Angiotensin II to the Blood Vessel Wall Hypertension, January 1, 1998; 31(1): 368 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. M. van Kesteren, A. H. J. Danser, F. H. M. Derkx, D. H. W. Dekkers, J. M. J. Lamers, P. R. Saxena, and M. A. D. H. Schalekamp Mannose 6-Phosphate Receptor–Mediated Internalization and Activation of Prorenin by Cardiac Cells Hypertension, December 1, 1997; 30(6): 1389 - 1396. [Abstract] [Full Text]
|
|